Le Lézard
Classified in: Science and technology
Subject: OFR

Leading AI Provider Xiao-I Corporation Announces Closing of Initial Public Offering


NEW YORK, March 13, 2023 /PRNewswire/ -- China's leading AI company Xiao-I Corporation ("Xiao-I" or the "Company") announced on March 9, 2023, Xiao-I was officially listed on NASDAQ with the stock symbol "AIXI". The successful listing of Xiao-I and its positive acceptance by U.S. investors set off a boom of Chinese technology companies in U.S. capital markets.

"We are extremely excited about Xiao-I's IPO as the humanity embarks on a new chapter of AI development and adoption triggered by ChatGPT." Said Max (Hui) Yuan, Founder and CEO of Xiao-I. "For the past 20 years, Xiao-I has been focusing on developing advanced cognitive intelligence solutions to empower businesses and consumers and we believe we are extremely well positioned in this new AI era."

As a leading AI provider in China, Xiao-I has the cognitive intelligence platform--CIAI (Cognitive Intelligence AI), which was developed independently and has its own intellectual property rights in China and has achieved large-scale commercialization and adoption. Going forward, Xiao-I plans to integrate the technical path of ChatGPT, shape rich digital intelligence products with the technical platform, product architecture and application data rooted in China, continue to promote the implementation of AI+intelligent customer service, AI+construction, AI+smart city and other industry application scenarios, empower more industries and businesses in China and around the world.

About Xiao-I

Founded in 2001, Xiao-I is the pioneer of China's self-developed virtual chatbot technology with its own intellectual property rights (Chinese invention patent ZL200410053749.9), focusing on the large-scale commercialization of patented technologies and original achievements related to cognitive intelligence based on natural language processing. It has served hundreds of large and medium-sized enterprises so far and has a leading market share in several vertical industries.

Xiao-I's continuous innovation capability is the basis for its leading position in the AI industrialization. Xiao-I's cognitive intelligence platform--CIAI (Cognitive Intelligence AI) is independently developed and has its own intellectual property rights. CIAI combines six core technologies including: natural language processing, speech processing, computer vision, machine learning, emotional computing, data intelligence and super automation, to form AI+contact center, AI+finance, AI+city public service, AI+metaverse, AI+manufacturing, and AI+medical, etc.

Media Contact:
Chao Xu
+86 18501721963
[email protected]

SOURCE Xiao-I Corporation


These press releases may also interest you

at 14:01
Midea, the world's largest producer of major appliances and a leading innovator in the HVAC industry, announced the launch of its EVOX G3 heat pump system. This latest generation of the EVOX series, featuring the EVOX G3 Heat Pump and EVOX G3 Air...

at 14:00
Canada's pollution pricing system creates incentives for industries to reduce their greenhouse gas emissions, drives innovation and sustainable business practices, and fosters a cleaner, more environmentally responsible future. Through the...

at 14:00
Making the switch to an electric vehicle (EV) is a win-win for families looking to save money while reducing pollution. Due to cheaper refuelling and lower maintenance costs, most EVs cost less than their gas engine counterparts over their lifetime....

at 13:45
Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceuticals company, today announced its standalone and consolidated results for the Fourth Quarter (Q4) and Full Year (FY) ended 31st March 2024.     Consolidated Financial...

at 13:40
WNS (Holdings) Limited , a leading provider of global digital-led Business Process Management (BPM) solutions, announced the filing of the Company's Annual Report on Form 20-F for the fiscal year ended March 31, 2024 with the United States Securities...

at 13:36
Remission Medical, the largest national virtual clinic offering diagnosis and longitudinal care in Rheumatology, powered by video visits and a technology platform focused on escalation avoidance, is now in its third year....



News published on and distributed by: